Safety Evaluation of Adverse Reactions in Diabetes
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Exenatide (Primary) ; Gliclazide (Primary) ; Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms SAFEGUARD
- 06 Feb 2018 Status changed from active, no longer recruiting to completed.
- 13 Jun 2017 Results (n=32) presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
- 23 Sep 2016 New trial record